Viewing Study NCT03331458


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-03-01 @ 6:28 AM
Study NCT ID: NCT03331458
Status: COMPLETED
Last Update Posted: 2019-08-26
First Post: 2017-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
Sponsor: Duke University
Organization:

Study Overview

Official Title: Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
Status: COMPLETED
Status Verified Date: 2019-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PACMen
Brief Summary: Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about physical activity levels prior to treatment and whether providing an exercise intervention pre-treatment may improve functional capacity during treatment.

The purpose of this study is to

1. Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and
2. Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe:

1. Examine intervention safety and tolerance by self-report
2. Examine changes in functional capacity by 6-minute walk test
3. Examine changes in symptom experience by self-report
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: